LAMA=long-acting muscarinic antagonist.
LONHALA is designed specifically for use with MAGNAIR.
Visit sunovionprofile.com/lonhala-magnair to learn more
The first and only nebulized LAMA for COPD
LONHALA™ MAGNAIR™ (glycopyrrolate) is an anticholinergic indicated for the long-term maintenance
treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD),
including chronic bronchitis and/or emphysema.
For additional information, please see the Brief Summary of Prescribing Information on the adjacent
pages. Please see full Prescribing Information and Patient Information for LONHALA MAGNAIR at
LONHALA and are trademarks of Sunovion Pharmaceuticals Inc. MAGNAIR is a trademark of PARI Pharma Gmb H, used under license. eLete is a registered trademark of PARI Pharma GmbH.
SUNOVION and are registered trademarks of Sumitomo Dainippon Pharma Co., Ltd. Sunovion Pharmaceuticals Inc. is a U.S. subsidiary of Sumitomo Dainippon Pharma Co., Ltd.
©2017 Sunovion Pharmaceuticals Inc. All rights reserved. 12/17 LON040-17